Intrexon | XON - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Agenus USD 95.28M 38.15M 2026-03
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Anika Therapeutics USD 93.56M 9.8M 2026-03
Arrowhead Research USD 1.84B 665.36M 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Heron Therapeutics USD 228.98M 9.08M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Intrexon USD 23.72M 45.04M 2024-06
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Ligand Pharmaceuticals USD 865.42M 33.14M 2026-03
MacroGenics USD 182.52M 37.42M 2026-03
MannKind USD 251.16M 40.42M 2026-03
Merck USD 35.02B 8.5B 2026-03
Novartis USD 26.61B 3.85B 2026-03
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Veracyte USD 522.17M 33.8M 2026-03
Xencor USD 482.85M 116.97M 2026-03